CK2 inhibitor CX-4945 targets EWS-FLI1 signaling network and shows therapeutic efficacy in metastatic mouse models of Ewing Sarcoma
Muhammad Daniyal, Rajesh Rajaiah, Upendarrao Golla, Marudhu Pandiyan Shanmugam, Chloe Sholler, Jeremy Hengst, Abhinav Beeravally Nagulapally, Hannah Valensi, Lanza Matthew, Yasin Uzun, Giselle L. Saulnier Sholler, Chandrika Gowda Behura
This study shows that CK2 inhibitor CX-4945 targets EWS-FLI1 and reduces tumor growth and metastasis in Ewing Sarcoma models.
bioRxiv · Sep 24, 2025 · PreprintCancer Biology